The results of TMA also confirmed that IGF2BP3 was significantly up-regulated in melanoma, and also confirmed that SPRR1B was significantly down-regulated in metastatic cancer before tumor invasion and metastasis. The gene discussed is IGF2BP3; the disease is neoplasm.